Tango Therapeutics, Inc. financial data

Symbol
TNGX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 803% % 4.6%
Debt-to-equity 39% % -29%
Return On Equity -50% % 9.2%
Return On Assets -36% % -1.3%
Operating Margin -178% % 48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 142,688,851 shares 32%
Common Stock, Shares, Outstanding 135,940,454 shares 26%
Entity Public Float $528,400,000 USD -38%
Common Stock, Value, Issued $136,000 USD 26%
Weighted Average Number of Shares Outstanding, Basic 116,166,187 shares 6.4%
Weighted Average Number of Shares Outstanding, Diluted 116,166,187 shares 6.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $62,384,000 USD 48%
Research and Development Expense $132,165,000 USD -8.2%
General and Administrative Expense $41,508,000 USD -5.1%
Operating Income (Loss) $111,289,000 USD 24%
Nonoperating Income (Expense) $9,699,000 USD -37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $101,590,000 USD 22%
Income Tax Expense (Benefit) $4,000 USD -98%
Net Income (Loss) Attributable to Parent $101,594,000 USD 22%
Earnings Per Share, Basic -0.87 USD/shares 27%
Earnings Per Share, Diluted -0.87 USD/shares 27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $112,279,000 USD 61%
Marketable Securities, Current $230,859,000 USD 23%
Cash, Cash Equivalents, and Short-term Investments $343,100,000 USD 33%
Assets, Current $353,756,000 USD 33%
Property, Plant and Equipment, Net $6,868,000 USD -15%
Operating Lease, Right-of-Use Asset $35,624,000 USD -9.8%
Other Assets, Noncurrent $303,000 USD 7475%
Assets $398,690,000 USD 26%
Accounts Payable, Current $1,182,000 USD -26%
Employee-related Liabilities, Current $9,046,000 USD 1.1%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $21,679,000 USD -43%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $30,832,000 USD -9.4%
Liabilities $52,511,000 USD -55%
Accumulated Other Comprehensive Income (Loss), Net of Tax $224,000 USD -33%
Retained Earnings (Accumulated Deficit) $603,152,000 USD -20%
Stockholders' Equity Attributable to Parent $346,179,000 USD 74%
Liabilities and Equity $398,690,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $41,697,000 USD -10%
Net Cash Provided by (Used in) Financing Activities $42,982,000 USD
Net Cash Provided by (Used in) Investing Activities $30,597,000 USD
Common Stock, Shares Authorized 400,000,000 shares 100%
Common Stock, Shares, Issued 135,940,454 shares 26%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,098,000 USD -83%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $114,846,000 USD 59%
Deferred Tax Assets, Valuation Allowance $186,603,000 USD 19%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $197,922,000 USD 17%
Operating Lease, Liability $33,570,000 USD
Depreciation $622,000 USD -0.48%
Payments to Acquire Property, Plant, and Equipment $51,000 USD -74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $101,706,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid $44,367,000 USD
Property, Plant and Equipment, Gross $17,406,000 USD 5.7%
Operating Lease, Liability, Current $2,738,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,949,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $5,308,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,797,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,128,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $78,500,000 USD 156%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,312,000 USD
Additional Paid in Capital $948,971,000 USD 35%
Deferred Tax Assets, Net of Valuation Allowance $11,319,000 USD -9.1%
Share-based Payment Arrangement, Expense $26,430,000 USD -8.5%